EFPIA - NEWSLETTER

EFPIA Newsletter 18 January 2018

IMI2 Call 14 draft topics published

IMI2 Call 14 will be launched in March, and draft topics are already available on the IMI Future topics page. Please feel free to disseminate.

Call 14 will include four topics, focused on immunology, digital health and clinical trials, as well as machine-leaning:

The official launch is expected on 15 March 2018, with the submission deadline for short proposals is on 14 June 2018.

For any additional detail, please contact science-policy@efpia.eu.

Events

23 JAN 2018

15122017 Patients as Partners EU London, UK

How to involve patients throughout the entire medicines development lifecycle, to drive greater efficiencies in clinical...

Learn more →

31 JAN 2018

17012018 Digital Health - Improving Prevention, Prediction and Care A Global, European... Allianz Forum, Berlin, Germany

An event organised by German Healthcare Partnership, Merck and vfa

Learn more →

White Paper - The impact of the manufacturing waiver on the European patent extension mechanism

What we are reading

AMR Industry Alliance progress report 18 January 2018 (AMR Industry Alliance)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶